NewcelX Ltd is a clinical-stage biopharmaceutical company focused on developing transformative therapies. Built on a validated human pluripotent stem cell (hPSC) platform, the Company's main program, NCEL-101, is designed to restore functional insulin production through scalable, off-the-shelf cell replacement. It is advancing a comprehensive therapeutic approach for Type 1 Diabetes, integrating cell therapy, immune protection, and translational science, including a phase IIa clinical trial for the treatment of Amyotrophic Lateral Sclerosis (ALS) in the field of regenerative medicine, as well as the development of treatments for Central Nervous System (CNS) disorders, including Narcolepsy, utilizing its Doxa platform. Its products are Holistic, IsletRx, AstroRx, and the DOXA platform.
Last trade$0.00
Day change$0.00 (0.00%)
Day range$2.00 – $2.66
Volume6,646
Market cap$16M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
No ratio data was found for NCEL.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
No quarterly
income statement data was found for NCEL.
Recent news
Company coverage with links to the original publishers.
NewcelX Ltd. (Nasdaq: NCEL) announced a binding term sheet to divest its Mazindol asset portfolio to REA Holdings Inc. for $500,000 upfront ($30,000 cash and $470,000 in equity representing 9.4% stake), plus up to $55 million in potential milestone payments and tiered royalties of 2-8% on global net sales. The divestiture allows NewcelX to focus on its core cell-therapy pipeline for Type 1 Diabetes while preserving potential value for CVR holders.
NewcelX, a Swiss clinical-stage biopharmaceutical company, announced a strategic roadmap update after merging with NLS Pharmaceutics Ltd., focusing on developing cell-based and small-molecule therapies for neurodegenerative and metabolic diseases.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.